Results 61 to 70 of about 929 (148)

Gene Therapy of Sphingolipid Metabolic Disorders. [PDF]

Int J Mol Sci, 2023
Shaimardanova AA, Solovyeva VV, Issa SS, Rizvanov AA.   +3 more
europepmc   +1 more source

Sphingolipidoses: molecular manifestations and biochemical strategies.

Journal of Lipid Research, 1978
P G Pentchev, J A Barranger
doaj   +1 more source

Neurological Consequences of Sphingosine Phosphate Lyase Insufficiency. [PDF]

Front Cell Neurosci, 2022
Atreya KB, Saba JD.
europepmc   +1 more source

A zebrafish model of combined saposin deficiency identifies acid sphingomyelinase as a potential therapeutic target. [PDF]

Dis Model Mech, 2023
Zhang T, Alonzo I, Stubben C, Geng Y, Herdman C, Chandler N, Doane KP, Pluimer BR, Trauger SA, Peterson RT.   +9 more
europepmc   +1 more source

The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C. [PDF]

Biochem Soc Trans, 2023
Platt FM.
europepmc   +1 more source

Sphingolipidoses: expanding the spectrum of α-synucleinopathies. [PDF]

J Neural Transm (Vienna)
Erskine D, Bronowska AK, Outeiro TF, Attems J.   +3 more
europepmc   +1 more source

Cardiac Gangliosides in Sphingolipidoses

Experimental Biology and Medicine, 1969
L, Schneck, W, Kleinberg, B W, Volk
openaire   +2 more sources

Genetic Modeling of Lysosomal Storage Disorders (LSDs) in the Brain-Midgut Axis of <i>Drosophila melanogaster</i> During Aging. [PDF]

Cells
Markaki SP, Kiose NM, Charitopoulou ZA, Kougioumtzoglou S, Velentzas AD, Stravopodis DJ.   +5 more
europepmc   +1 more source

The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases. [PDF]

Prog Neurobiol
Lane-Donovan C, Paredes M, Kao AW.
europepmc   +1 more source

Targeting Glucosylceramide Synthase: Innovative Drug Repurposing Strategies for Lysosomal Diseases. [PDF]

Int J Mol Sci
Canini G, Mazzinelli E, Nocca G, Lattanzi W, Arcovito A.   +4 more
europepmc   +1 more source